NextWave Wireless to Showcase New Mobile Multimedia Products and Technologies at Mobile World Congress 2008
New Products to Enable Next-Generation Mobile Devices and Subscriber Services
Archive for January, 2008
The International Myeloma Foundation Says New Treatment Regimen for Older Patients Could Soon Be Approved in Europe
Positive Opinion from EU Advisory Committee Could Mark the Return of Thalidomide to Europe
The Gores Group Completes Acquisition of Sagem Communications
LOS ANGELES–(BUSINESS WIRE)–Jan. 29, 2008–The Gores Group, a
leading U.S. investment firm, announced today that it closed its
acquisition of Sagem Communications from SAFRAN for an enterprise
value of 383 million euros (560 million dollars at current exchange
rate).
Sagem Communications is one of France’s premier technology
companies specializing in broadband communications and convergence
activities. Products include digital […]
The Medicines Company’s Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
PARSIPPANY, N.J.–(BUSINESS WIRE)–Jan. 29, 2008–The Medicines
Company (NASDAQ: MDCO) today announced the receipt of the European
Commission Decision authorizing an expanded use for Angiox(R)
(bivalirudin) in adult patients with acute coronary syndromes (ACS),
specifically patients with unstable angina (UA) or non-ST segment
elevation myocardial infarction (NSTEMI) planned for urgent or early
intervention, when used with aspirin and clopidogrel.
[…]
AngioScore Obtains Japanese Approval for AngioSculpt Scoring Balloon Catheter
FREMONT, Calif.–(BUSINESS WIRE)–Jan. 28, 2008–AngioScore, Inc.,
a developer of novel angioplasty catheters for use in the treatment of
cardiovascular disease, announced today that its flagship product, the
AngioSculpt(R) Scoring Balloon Catheter, has received import approval
from Japan’s Ministry of Health, Labor and Welfare (MHLW/PMDA) for the
interventional treatment of coronary artery disease in that country.
AngioScore and […]
Private Equity Council Issues Statement on New PE Research Conducted by Prof. Josh Lerner for the World Economic Forum
WASHINGTON–(BUSINESS WIRE)–Jan. 25, 2008–The Private Equity
Council today issued the following statement on new research on
private equity conducted for the World Economic Forum by a team of
researchers led by Josh Lerner, the Jacob H. Schiff Professor of
Investment Banking at Harvard Business School. The studies are
available on the WEF web site at www.weforum.org. The statement should
be attributed […]
Celgene Reports on REVLIMID(R) (Lenalidomide) Global Regulatory Developments in Multiple Myeloma and Deletion 5Q Myelodysplastic Syndromes
REVLIMID in combination with dexamethasone receives Marketing Authorisation Approval for relapsed/refractory multiple myeloma in Australia
REVLIMID receives conditional Marketing Authorisation Approval for deletion 5q MDS in Canada
Lenalidomide - Celgene Europe receives Negative Opinion on Marketing Authorisation Application for deletion 5q MDS in European Union (EU)
Dell Opens Second European Plant to Meet Growing Customer Demand
Michael Dell Attends Opening Event at New Lodz, Poland Facility
Response Genetics, Inc. to Perform the MAGE-A3 Screening Assay for the Current GlaxoSmithKline Phase III Novel MAGE-A3 Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
LOS ANGELES–(BUSINESS WIRE)–Jan. 22, 2008–Response Genetics,
Inc. (NASDAQ: RGDX) today announced that it has begun performing the
MAGE-A3 gene expression screening assay for GlaxoSmithKline’s (GSK)
Phase III clinical trial of the investigational MAGE-A3
Antigen-Specific Cancer Immunotherapeutic (ASCI) as adjuvant therapy
in MAGE-A3 positive patients with stage IB, II or IIIA Non-Small Cell
Lung Cancer (NSCLC). These assays will be performed in […]
Airbiquity Announces $25 Million Funding
Ignition Partners Joins Acorn Ventures, Kirnaf LTD and Shell Internet Ventures in Financing Round to Support New VIAaq Managed Data Service and International Growth